Jun 15, 2022
Procleix Plasmodium assay receives CE mark!
This is the first nucleic acid test (NAT) on an automated NAT system to detect the presence of Plasmodium species in blood donors, reducing the risk of transfusion-transmitted infections by this parasite responsible for over 240 million infections and 620,000 deaths annually.
The Procleix Plasmodium Assay uses Transcription-Mediated Amplification (TMA) to detect the presence of ribosomal RNA of five species of Plasmodium parasites (P. falciparum, P. knowlesi, P. malariae, P. ovale, and P. vivax) in whole blood samples.
This assay helps to reduce the transfusion of infected blood, even when the donor does not exhibit symptoms and traditional screening techniques cannot detect the presence of the pathogen.
More information to come. Stay tuned!